Gene: TGFBI
Official Full Name: transforming growth factor beta inducedprovided by HGNC
Gene Summary: This gene encodes an RGD-containing protein that binds to type I, II and IV collagens. The RGD motif is found in many extracellular matrix proteins modulating cell adhesion and serves as a ligand recognition sequence for several integrins. This protein plays a role in cell-collagen interactions and may be involved in endochondrial bone formation in cartilage. The protein is induced by transforming growth factor-beta and acts to inhibit cell adhesion. Mutations in this gene are associated with multiple types of corneal dystrophy. [provided by RefSeq, Jul 2008]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO35018 | TGFBI Knockout cell line (HeLa) | Human | TGFBI | 1:3~1:6 | Negative | Online Inquiry |
KO35019 | TGFBI Knockout cell line (HCT 116) | Human | TGFBI | 1:2~1:4 | Negative | Online Inquiry |
KO35020 | TGFBI Knockout cell line (A549) | Human | TGFBI | 1:3~1:4 | Negative | Online Inquiry |
TGFBI Gene Knockout Cell Lines are genetically modified cellular models designed to facilitate the study of the TGFBI gene, which encodes a protein known to play critical roles in cell adhesion, migration, and extracellular matrix organization. By employing advanced CRISPR-Cas9 gene editing technology, these cell lines have been accurately engineered to eliminate the expression of the TGFBI gene. This knockout approach allows researchers to observe the phenotypic and molecular changes resulting from the absence of TGFBI, providing insights into its biological functions and contributions to various disease states, including cancer and fibrotic disorders.
The primary function of the TGFBI protein is to interact with integrins and other matrix components, thereby influencing cellular behaviors such as proliferation and differentiation. In this knockout model, scientists can elucidate the pathways involved in cell signaling and tissue repair, identifying potential therapeutic targets for treating diseases associated with dysregulated TGFBI expression. This cell line serves as a powerful tool in both basic and applied research, bridging the gap between molecular biology and regenerative medicine.
Unlike traditional cell lines, TGFBI Gene Knockout Cell Lines offer the unique advantage of a complete ablation of the gene of interest, which leads to more accurate modeling of TGFBI-related pathophysiology. This specificity can significantly enhance the reliability of experimental outcomes. Moreover, the versatility of these cell lines allows for various experimental manipulations, including drug testing and gene expression assays.
Researchers and clinicians looking to understand the role of TGFBI or to develop targeted therapies will find immense value in these knockout cell lines. The capacity to dissect the molecular intricacies of TGFBI-related signaling pathways can pave the way for novel therapeutic interventions, thus holding substantial promise for advancing patient care and therapeutic strategies.
Our company specializes in providing high-quality genetic tools and cell lines that meet rigorous scientific standards. With a dedicated team of experts in molecular biology and genetics, we are committed to supporting the research community with innovative products that drive discovery and innovation.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.